The Liver Fibroinflammatory Marker Ct1 Is Reduced With Aldafermin Therapy In A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study In Patients With Non-Alcoholic Steatohepatitis
JOURNAL OF HEPATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要